Key Players Such As AbbVie, Roche, And Amgen Dominate The Competitive Landscape Of The Expanding Cytokine Market

DUBLIN, Nov. 2, 2023 /PRNewswire/ -- The "Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

The global cytokine market, with a market size of US$ 83.3 Billion in 2022, is expected to experience substantial expansion in the years ahead. Analysts anticipate the market to reach US$ 130.5 Billion by 2028, showcasing a notable Compound Annual Growth Rate (CAGR) of 7.66% during the period from 2023 to 2028.

Cytokines, a group of proteins, peptides, or glycoproteins, play a pivotal role in controlling the growth and activity of immune system and blood cells. These high-affinity picomolar concentrations regulate immunity, inflammation, and hematopoiesis. Typically administered under the skin, into muscles, or veins, cytokines aid in managing chemotherapy side effects and treating cancer.

They enhance anti-cancer activities by sending signals that induce abnormal cells to die and prolong the lifespan of normal cells. Furthermore, cytokines are gaining widespread adoption in cell and gene therapy, facilitating the expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches.

Cytokine Market Trends

The global demand for solutions targeting cytokines has surged due to the ongoing COVID-19 pandemic. The excessive production of proinflammatory cytokines induced by the virus can lead to acute respiratory distress syndrome (ARDS), tissue damage, multi-organ failure, and death. As a result, there is a growing need for cytokine-targeting solutions to manage patients, enhance survival rates, and reduce mortality.

Additionally, the increasing prevalence of cancer, coupled with the rising demand for minimally invasive surgeries (MIS) known for reduced post-operative pain, fewer complications, and quicker recovery, is propelling market growth. Cytokines are also gaining traction as diagnostic, prognostic, and therapeutic agents and biomarkers for various health and disease applications, including immune cell differentiation, inflammation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis.

Moreover, the rising cases of atopic dermatitis (AD), an inflammatory skin disease characterized by severe itchiness, are driving demand for novel cytokines to better understand the pathogenesis of AD and develop improved therapeutic targets.

Key Market Segmentation

The comprehensive report provides insights into key market trends within sub-segments of the global cytokine market, along with forecasts at global, regional, and country levels for the period from 2023 to 2028. The market is segmented based on cytokine type, therapeutic application, and end user as follows:

Breakup by Cytokine Type:

Tumor Necrosis Factor-TNF
Interleukins-Il
Interferons-IFN
Epidermal Growth Factor-EGF
Others

Breakup by Therapeutic Application:

Cancer
Asthma and Airway Inflammation
Arthritis
Others

Breakup by End User:

Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic and Research Institutes

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape

The competitive landscape of the industry is robust and features key players, including AbbVie Inc., Abcam plc, Amgen Inc., Applied Biological Materials Inc. (abm), Bio-Techne Corporation, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc., and UCB S.A.

Key Questions Answered in This Report

How has the global cytokine market performed to date, and what are the prospects for the future?
What impact has COVID-19 had on the global cytokine market?
What are the key regional markets for cytokines?
What is the market segmentation based on cytokine type, therapeutic application, and end user?
What are the factors driving and challenging market growth?
Who are the key players in the global cytokine market, and what is the level of competition?

For more information about this report visit https://www.researchandmarkets.com/r/kk50t9

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/key-players-such-as-abbvie-roche-and-amgen-dominate-the-competitive-landscape-of-the-expanding-cytokine-market-301975781.html

SOURCE Research and Markets

First published on Fri, Nov 3, 2023

Liked what you read? That’s only the tip of the tech iceberg!

Explore our vast collection of tech articles including introductory guides, product reviews, trends and more, stay up to date with the latest news, relish thought-provoking interviews and the hottest AI blogs, and tickle your funny bone with hilarious tech memes!

Plus, get access to branded insights from industry-leading global brands through informative white papers, engaging case studies, in-depth reports, enlightening videos and exciting events and webinars.

Dive into TechDogs' treasure trove today and Know Your World of technology like never before!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.

Tags:

ResearchAndMarkets Cytokine Atopic Dermatitis (AD) Neurobiology

Join The Discussion

- Promoted By TechDogs -

Market Research